BioSpace News Archive

Masimo (NASDAQ: MASI) today announced that its management is scheduled to present at the Barclays Global Healthcare Conference at the Loews Miami Beach Hotel on Tuesday, March 13, 2018 at 4:20 p.m. Eastern Time.

Pfizer Inc. invites investors and the general public to view and listen to a webcast of a presentation by Andy Schmeltz, Global President, Oncology, and Chris Boshoff, Senior Vice President and Head, Immuno-Oncology, Early Development and Translational Oncology, at the Cowen and Company 38th Annual Healthcare Conference on Wednesday, March 14, 2018 at 10:40 a.m. Eastern Daylight Time.

- Primary endpoint met for evobrutinib (Bruton’s Tyrosine Kinase Inhibitor - BTK) in relapsing multiple sclerosis (MS) - First proof of concept for BTK inhibitor in MS

Nashville-based data science company IQuity has announced the release of IsolateFibromyalgia™, a pioneering blood test that uses RNA analysis to help health care providers accurately and quickly detect fibromyalgia syndrome.

Relay Therapeutics, a biotech company dedicated to developing breakthrough medicines by leveraging insights from protein motion, today announced that Sanjiv Patel, M.D., President and Chief Executive Officer, will present at Cowen and Company’s 38th Annual Health Care Conference.

MYM Nutraceuticals Inc. is pleased to announce Dr. Charith Adkar has joined MYM as its new Chief Science Officer (CFO) effective immediately.

On February 2, 2018, Premier Biotech Inc. was granted a coveted 510(k) clearance for the following drugs Amphetamine, Cocaine, Marijuana, Methamphetamine, Opiates and Phencyclidine from the Food and Drug Administration (FDA) for OralTox®.

CTI BioPharma Inc. reported financial results for the fourth quarter and full year ended December 31, 2017.

The American College of Medical Genetics and Genomics (ACMG) has long been an outspoken advocate on the need for knowledgeable health professionals to be involved in interpreting the clinical implications of the results of genetic testing for a specific individual, and the equally important need for professionals be involved in advising people of which test is most useful for them, if any.

MedX Health Corp. announces that it has received notice from the TSX-V accepting an Investor Relations Agreement entered into with Mi3 Communications Financières Inc. with an effective date of December 1, 2017.